Nutritional Advice El Mondo
Objectives:
The number of positive and death cases from coronavirus disease 2019 (COVID-19) is still increasing. The identification of risk factors for severe outcomes is important. Dyslipidemia (is an abnormal amount of lipids (e.g. triglycerides, cholesterol and/or fat phospholipids) in the blood) has been shown as a long-known risk factor for cardiovascular disease. Therefore, this review article has been conducted.
Is dyslipidemia associated with severe COVID-19 infections?
Study design:
This review article included 7 studies with a total of 6,922 COVID-19 patients.
Results and conclusions:
The investigators found meta-analysis showed that dyslipidemia was associated with severe COVID-19 infections [RR = 1.39, 95% CI = 1.03 to 1.87, p = 0.03, I2 = 57%, random-effect modelling].
The investigators concluded dyslipidemia increases the risk of the development of severe outcomes from COVID-19 infections. Patients with dyslipidemia should be monitored closely to minimize the risk of COVID-19.
Original title:
Dyslipidemia is associated with severe coronavirus disease 2019 (COVID-19) infection by Hariyanto TI and Kurniawan A.
Link:
https://pubmed.ncbi.nlm.nih.gov/32771919/
Additional information of El Mondo:
Find more information/studies on coronavirus right here.